SOPHiA GENETICS SA (90B.F)
- Previous Close
2.9000 - Open
2.7600 - Bid 2.7400 x --
- Ask 2.8000 x --
- Day's Range
2.7600 - 2.7600 - 52 Week Range
2.3600 - 5.0000 - Volume
116 - Avg. Volume
240 - Market Cap (intraday)
184.454M - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
-- - EPS (TTM)
-0.8300 - Earnings Date May 6, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.
www.sophiagenetics.com423
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 90B.F
View MorePerformance Overview: 90B.F
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 90B.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 90B.F
View MoreValuation Measures
Market Cap
185.13M
Enterprise Value
141.12M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.35
Price/Book (mrq)
2.29
Enterprise Value/Revenue
2.47
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-95.89%
Return on Assets (ttm)
-23.02%
Return on Equity (ttm)
-50.41%
Revenue (ttm)
65.17M
Net Income Avi to Common (ttm)
-62.49M
Diluted EPS (ttm)
-0.8300
Balance Sheet and Cash Flow
Total Cash (mrq)
80.23M
Total Debt/Equity (mrq)
31.12%
Levered Free Cash Flow (ttm)
-28.36M